H-1B sponsorship profile: BioMarin Pharmaceutical Inc. Across U.S. Department of Labor LCA disclosures, BioMarin Pharmaceutical Inc filed 101 Labor Condition Applications covering 101 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 99% (100 certified of 101 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on BioMarin Pharmaceutical Inc’s H-1B petitions range from $60,757 at the low end to $252,331 at the high end, with a petition-weighted average of $132,818. That range reflects the mix of occupations the company sponsors, led by Scientist 1, Tech Ops (3 petitions at $111,374 avg), followed by Scientist 1, Gene Therapy Research and VP, Head of Commercial Digital Strategy and Transformation. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. BioMarin Pharmaceutical Inc is headquartered in NOVATO, CA under NAICS code 325414, and places H-1B workers across 6 states, most heavily in CA, TX, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where BioMarin Pharmaceutical Inc ranks. By H-1B petition volume, BioMarin Pharmaceutical Inc is #2,226 of 119,880 employers nationally and #358 of 22,893 employers headquartered in CA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.